Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:163-169

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broeders, M. A. W.
Right arrow Articles by Egbrink, M. G. A. o.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broeders, M. A. W.
Right arrow Articles by Egbrink, M. G. A. o.
Related Collections
Right arrow Animal models of human disease
Right arrow Arterial thrombosis
Right arrow Deep vein thrombosis
Right arrow Platelet function inhibitors
Right arrow Platelets
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:163.)
© 2001 American Heart Association, Inc.


Thrombosis

Endogenous Nitric Oxide and Prostaglandins Synergistically Counteract Thromboembolism in Arterioles but Not in Venules

Martijn A. W. Broeders; Geert-Jan Tangelder; Dick W. Slaaf; Robert S. Reneman; Mirjam G. A. oude Egbrink

From the Departments of Physiology (M.A.W.B., R.S.R., M.G.A. oude E.) and Biophysics (D.W.S.), Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands; and the Laboratory for Physiology (G.-J.T.), Institute for Cardiovascular Research, Free University, Amsterdam, the Netherlands.

Correspondence to M.G.A. oude Egbrink, PhD, Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University, Universiteitssingel 50, PO Box 616, 6200 MD Maastricht, the Netherlands. E-mail m.oudeegbrink{at}fys.unimaas.nl

Abstract—It has been shown that NO and prostacyclin (prostaglandin I2) from cultured endothelium synergistically inhibit blood platelet aggregation in vitro. However, it is unknown whether this synergism is also effective in the inhibition of thromboembolism in vivo and, if it is, whether it differs between vessel types. Therefore, the effect of endogenous NO and prostacyclin, in combination or alone, on thromboembolism was studied in an in vivo model. Thromboembolism was induced by micropipette puncture of rabbit mesenteric arterioles and venules (diameter 18 to 40 µm). In addition, the influence of wall shear rate was analyzed. In arterioles, the combined inhibition of NO synthase (NG-nitro-L-arginine [L-NA] 0.1 mmol/L; local superfusion) and of cyclooxygenase (aspirin [ASA] 100 mg/kg IV) resulted in a pronounced, significant prolongation of embolization duration (median >600 seconds) compared with control (median 153 seconds) or treatment with either L-NA (234 seconds) or ASA (314 seconds). This combined effect of L-NA+ASA was greater than the sum of the individual effects of L-NA and ASA. In contrast, in venules L-NA+ASA had no additional effect on embolization duration (209 seconds) compared with the effect of L-NA alone (230 seconds); ASA alone had no effect (122 seconds; control 72 seconds). Interestingly, only in the L-NA+ASA arterioles did embolization correlate positively with wall shear rate (rs=0.687; P=0.028). In conclusion, this study indicates that in arterioles, but not in venules, endogenous NO and prostaglandins synergistically counteract ongoing thromboembolism after vessel wall injury and that the combination of endogenous NO and prostaglandins appears to protect against enhancement of arteriolar thromboembolism by wall shear rate.


Key Words: vessel wall injury • thromboembolism pathophysiology • nitric oxide • prostaglandins • wall shear rate




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Lindenblatt, M. D. Menger, E. Klar, and B. Vollmar
Darbepoetin-Alpha Does Not Promote Microvascular Thrombus Formation in Mice: Role of eNOS-Dependent Protection Through Platelet and Endothelial Cell Deactivation
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1191 - 1198.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Borgdorff, G. J. Tangelder, and W. J. Paulus
Cyclooxygenase-2 Inhibitors Enhance Shear Stress-Induced Platelet Aggregation
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 817 - 823.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A.W. Broeders, G. J. Tangelder, D. W. Slaaf, R. S. Reneman, and M. G.A. oude Egbrink
Hypercholesterolemia Enhances Thromboembolism in Arterioles but Not Venules: Complete Reversal by L-Arginine
Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 680 - 685.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A.W. Broeders, G. J. Tangelder, D. W. Slaaf, R. S. Reneman, and M. G.A. oude Egbrink
Hypercholesterolemia Enhances Thromboembolism in Arterioles but Not Venules: Complete Reversal by L-Arginine
Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 680 - 685.
[Abstract] [Full Text] [PDF]